glp-1 drug market competition 2025

glp-1 drug market competition 2025 Receptor Agonist Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Unpacking $100B+ Obesity Market Opportunity:

Name: glp-1 drug market competition 2025 Receptor Agonist Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Unpacking $100B+ Obesity Market Opportunity:
Brand: plomberie-cannillo.fr
SKU: 96866191562
Price: 21.76 USD
Availability: InStock
Rating: 4.600300000000001 (18 reviews)

SKU: 96866191562

4.6

USD21.76 USD42.76

Pay in 4 interest-free payments of $5.44 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

This gel is suitable for all skin types and can be used daily for best results

Continued research led to the first GLP-1 drugs approved for weight loss in people with obesity or overweight: liraglutide or Saxenda in 2014, semaglutide as Wagovy in 2021 and tirzepatide as Zepbound in 2023